Brady Huggett is features editor at The Transmitter, where he writes and edits features and long-form projects. He is also the creator and host of the “Synaptic” podcast. Before joining The Transmitter in 2022, he served as business editor at Nature Biotechnology, and prior to that was the managing editor of BioWorld.
Brady Huggett
Features editor
The Transmitter
From this contributor
Releasing the Hydra with Rafael Yuste
By
Brady Huggett, Shaena Montanari
4 April 2025 | 10 min read
Timothy Ryan on his pivotal switch from studying particle physics to decoding synaptic transmission
By
Brady Huggett
1 October 2024 | 70 min listen
Biosensors and being fearless with Lin Tian
By
Brady Huggett
1 September 2024 | 62 min listen
Education
- M.A. in creative writing, The New School
- M.A. in journalism, University of North Carolina at Chapel Hill
- B.S. in biology from Wake Forest University in Winston-Salem, North Carolina
Explore more from The Transmitter
How to teach programming in the age of AI
Scientists and educators are concerned about students using artificial intelligence to shortcut their learning. But there are also opportunities, especially when it comes to teaching neuroscience students how to code.
How to teach programming in the age of AI
Scientists and educators are concerned about students using artificial intelligence to shortcut their learning. But there are also opportunities, especially when it comes to teaching neuroscience students how to code.
By
Ashley Juavinett
30 March 2026 | 8 min read
Neuroscience conference policy draws confusion, apology
NeurIPS organizers apologized and altered course after issuing a policy that barred submissions from researchers at U.S.-government-sanctioned institutions.
Neuroscience conference policy draws confusion, apology
NeurIPS organizers apologized and altered course after issuing a policy that barred submissions from researchers at U.S.-government-sanctioned institutions.
By
Dalmeet Singh Chawla
27 March 2026 | 5 min read
Funding for animal research alternatives reaches ‘inflection point’
The United States and Europe are dedicating hundreds of millions of dollars in funding to advance novel alternative methods, but not all neuroscientists see this as a positive step.
Funding for animal research alternatives reaches ‘inflection point’
The United States and Europe are dedicating hundreds of millions of dollars in funding to advance novel alternative methods, but not all neuroscientists see this as a positive step.
By
Claudia López Lloreda
26 March 2026 | 4 min read